Hormone Receptor Positive

11 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(4)

Drug	Company
arimidex	ASTRAZENECA PLC (AZN)
arimidex dummy	ASTRAZENECA PLC (AZN)
faslodex dummy	ASTRAZENECA PLC (AZN)
OP-1250	Olema Pharmaceuticals, Inc. (OLMA)

Phase 2(3)

Drug	Company
Eftilagimod Alfa	Structure Therapeutics Inc. (GPCR)
Eftilagimod Alfa	Filana Therapeutics Inc. (FLNA)
Iparomlimab and Tuvonralimab	Merus N.V. (MRUS)

Phase 1(4)

Drug	Company
avasopasem	Galera Therapeutics, Inc. (GRTX)
Denosumab	Aclaris Therapeutics, Inc. (ACRS)
Zoledronic acid	Aclaris Therapeutics, Inc. (ACRS)
Zumsemetinib	Aclaris Therapeutics, Inc. (ACRS)

BioSniper tracks 11 drugs in development for Hormone Receptor Positive across 7 companies.

There are 1 clinical trial targeting Hormone Receptor Positive tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.